StockTipsArenaBeta

BUY Anupam Rasayan India Limited — Nirav Chheda, Nirmal Bang Securities

BUYAnupam Rasayan India Limited
Anupam Rasayan India share price target & all analyst calls

byNirav Chheda, Nirmal Bang SecuritiesHorizon: NA (inferred Swing (≤2wk))22 Sept 2026via CNBC Awaaz.

Entry₹1,208.45Inferred
Target₹1,320
Total upside +9.23% (call closed)
Stop loss₹1,170-3.18% risk
Exit₹1,17029 Sept 2026, 3:00 pm
Stop-loss hit-3.18%
Follow Nirav Chheda for new calls(19% target hit, 103 closed calls)Get alertsWatch ANURAS for new buy/sell callsGet alertsSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 29 Sept 2026
2 supporting6 neutral0 opposing
Supports the BUY call (2)

Anupam Rasayan India Limited has completed the acquisition of Bliss GVS Pharma as part of its strategy to build an integrated global pharmaceutical platform.

NSE · Press Release·28 Sept · today

(opens in new tab)

The company has completed the acquisition of Bliss GVS Pharma as part of its strategic expansion.

BSE · Company Update·28 Sept · today

(opens in new tab)
Neutral / worth noting (6)

Anupam Rasayan India Limited is issuing non-convertible debentures on a private placement basis, which is a form of fundraising.

NSE · Issue of Securities·19 Sept · 1w ago

(opens in new tab)

Anupam Rasayan India Limited's Board approved the issuance of up to INR 1,600 crore of secured, rated, unlisted, redeemable, non-convertible debentures on a private placement basis. The proceeds will

NSE · Outcome of Board Meeting·19 Sept · 1w ago

(opens in new tab)

The Board of Directors approved the issuance of Non-Convertible Debentures on a private placement basis.

BSE · Board Meeting·19 Sept · 1w ago

(opens in new tab)

Anupam Rasayan India Limited's Board approved the execution of security documents for a wholly-owned subsidiary's INR 300 crore financing via NCDs. This includes a pledge of equity shares and a corpor

NSE · Outcome of Board Meeting·17 Sept · 2w ago

(opens in new tab)

Anupam Rasayan India Ltd's Board of Directors will meet on September 19, 2026, to consider and approve fund raising.

BSE · Board Meeting·16 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Anupam Rasayan India

All analyst calls on Anupam Rasayan India

More from Nirav Chheda, Nirmal Bang Securities

Every call and its outcome